Disease Trajectories and Anti-cytokine Response Signatures in Atopic Dermatitis and Psoriasis

Launched by UNIVERSITY HOSPITAL SCHLESWIG-HOLSTEIN · Nov 27, 2017

Keywords

ClinConnect Summary

This clinical trial is studying the long-term effects of chronic skin conditions like atopic dermatitis (often known as eczema) and psoriasis. Researchers want to understand how these diseases progress over time and how different targeted treatments can affect both the symptoms and the underlying biological processes. Participants will be asked to provide regular samples such as blood, skin biopsies, and other materials that will help scientists analyze inflammation and changes in the skin. The goal is to gather data for at least ten years to better understand how various treatments and external factors influence these skin conditions.

Anyone diagnosed with atopic dermatitis, psoriasis, or certain autoimmune skin diseases can participate, as long as they agree to join the study. For children under 18, no skin biopsies will be taken. Participants will not change their current treatments; this study is purely for gathering information to help improve future care. If you choose to join, you’ll be contributing to valuable research that could help many people with similar conditions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with a clinical diagnosis of atopic dermatitis, psoriasis or autoimmune skin disease
• • Written informed consent obtained from the subject
• Exclusion Criteria:
• • Patients who decline participation
• • In patients\<18 years of age no biopsies will be taken